WallStSmart

Dorman Products Inc (DORM)vsHesai Group Sponsored ADR (HSAI)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Hesai Group Sponsored ADR generates 48% more annual revenue ($3.18B vs $2.15B). HSAI leads profitability with a 14.8% profit margin vs 8.8%. HSAI appears more attractively valued with a PEG of 0.53. HSAI earns a higher WallStSmart Score of 53/100 (C-).

DORM

Buy

53

out of 100

Grade: C-

Growth: 4.0Profit: 6.5Value: 5.3Quality: 9.0
Piotroski: 7/9Altman Z: 3.38

HSAI

Buy

53

out of 100

Grade: C-

Growth: 6.7Profit: 4.0Value: 5.7Quality: 8.0
Piotroski: 3/9Altman Z: 2.93
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

DORMOvervalued (-14.4%)

Margin of Safety

-14.4%

Fair Value

$116.51

Current Price

$133.18

$16.67 premium

UndervaluedFair: $116.51Overvalued

Intrinsic value data unavailable for HSAI.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

DORM2 strengths · Avg: 9.0/10
Altman Z-ScoreHealth
3.3810/10

Safe zone — low bankruptcy risk

Price/BookValuation
2.7x8/10

Reasonable price relative to book value

HSAI4 strengths · Avg: 8.3/10
Debt/EquityHealth
0.119/10

Conservative balance sheet, low leverage

PEG RatioValuation
0.538/10

Growing faster than its price suggests

Price/BookValuation
2.0x8/10

Reasonable price relative to book value

Revenue GrowthGrowth
29.6%8/10

Revenue surging 29.6% year-over-year

Areas to Watch

DORM2 concerns · Avg: 3.0/10
Revenue GrowthGrowth
4.2%4/10

4.2% revenue growth

EPS GrowthGrowth
-23.5%2/10

Earnings declined 23.5%

HSAI4 concerns · Avg: 3.0/10
P/E RatioValuation
31.8x4/10

Premium valuation, high expectations priced in

Return on EquityProfitability
5.3%3/10

ROE of 5.3% — below average capital efficiency

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

EPS GrowthGrowth
-13.9%2/10

Earnings declined 13.9%

Comparative Analysis Report

WallStSmart Research

Bull Case : DORM

The strongest argument for DORM centers on Altman Z-Score, Price/Book. PEG of 1.17 suggests the stock is reasonably priced for its growth.

Bull Case : HSAI

The strongest argument for HSAI centers on Debt/Equity, PEG Ratio, Price/Book. Revenue growth of 29.6% demonstrates continued momentum. PEG of 0.53 suggests the stock is reasonably priced for its growth.

Bear Case : DORM

The primary concerns for DORM are Revenue Growth, EPS Growth.

Bear Case : HSAI

The primary concerns for HSAI are P/E Ratio, Return on Equity, Piotroski F-Score.

Key Dynamics to Monitor

DORM profiles as a value stock while HSAI is a growth play — different risk/reward profiles.

HSAI carries more volatility with a beta of 1.36 — expect wider price swings.

HSAI is growing revenue faster at 29.6% — sustainability is the question.

Monitor AUTO PARTS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

DORM scores higher overall (53/100 vs 53/100). Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Dorman Products Inc

CONSUMER CYCLICAL · AUTO PARTS · USA

Dorman Products, Inc. supplies replacement parts and fasteners for passenger cars, light trucks and heavy duty trucks to the automotive aftermarket industry in the United States, Canada, Mexico, Europe, the Middle East and Australia. The company is headquartered in Colmar, Pennsylvania.

Visit Website →

Hesai Group Sponsored ADR

CONSUMER CYCLICAL · AUTO PARTS · China

Hesai Group, engages in the development, manufacture, and sale of three-dimensional light detection and ranging solutions (LiDAR). The company is headquartered in Shanghai, China.

Want to dig deeper into these stocks?